Members |
targetComponentId |
Tic |
Tic (finding) |
Tic |
Tic (finding) |
Tic disorder |
Tic (finding) |
Tic disorder |
Tic disorder |
biverkning av ticarcillin och klavulansyra |
Adverse reaction to clavulanic acid and/or ticarcillin |
Ticarcillin disodium with clavulanate potassium |
Ticarcillin disodium |
Ticarcillin disodium with clavulanate potassium |
Clavulanate potassium (substance) |
fästingbett, utan infektion |
Bite of tick (event) |
fästingbett, utan infektion |
Tick bite |
Tick paralysis causing toxic effect |
Tick paralysis |
Tick-borne bunyavirus encephalitis |
Nairoviral encephalitis (disorder) |
Tick-borne bunyavirus fever |
Tick-borne orthobunyavirus fever |
Tick-borne bunyavirus fever |
Disease due to Nairovirus |
vaccin mot fästingburen encefalit |
Tick-borne encephalitis virus antigen-containing vaccine product |
vaccin mot fästingburen encefalit |
Tick-borne encephalitis virus antigen-containing vaccine product |
vaccin mot fästingburen encefalit, injektionsvätska, lösning, förfylld spruta |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne flavivirus encephalitis |
Encephalitis due to tick-borne encephalitis virus subgroup |
Tick-borne flavivirus encephalitis |
Tick-borne encephalitis |
Tick-borne viral encephalitis |
Tick-borne encephalitis |
Tick-borne viral encephalitis |
Viral encephalitis transmitted by tick |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Ability to sense tickle (observable entity) |
Tidal river |
Tidal river (environment) |
Tidal river |
Tidal river water (substance) |
Tile &/or slab caster |
Slab caster |
Tile &/or slab caster |
Tile/slab caster |
Tile &/or slab caster |
Slab caster |
Tile &/or slab caster |
Tile caster |
Tile &/or slab caster |
Tile/slab caster |
Tiler |
Tiler |
Tiler |
Floor/wall tiler (occupation) |
Tiler |
Tiler |
Tiler |
Floor/wall tiler (occupation) |
Time duration (property) (qualifier value) |
Time (attribute) |
Time duration (property) (qualifier value) |
Time (property) (qualifier value) |
sex meters gång på tid |
Timed six metre walk technique |
sex meters gång på tid |
Timed six meter walk time (observable entity) |
Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
timolol 0,1 %, flytande ögongel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
timolol 0,25 %, flytande ögongel |
Timolol (as timolol maleate) 2.5 mg/mL eye gel |
timolol 0,5 %, ögondroppar utan konserveringsmedel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
timolol 0,5 %, flytande ögongel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye gel (clinical drug) |
Timothy grass |
Phleum |
Timothy grass |
Phleum pratense (organism) |
timotejgräspollenallergen |
Timothy grass pollen (substance) |
Tinamou |
Order Tinamiformes (organism) |
Tinamou |
Family Tinamidae (organism) |
Tinea barbae |
Pseudofolliculitis barbae (disorder) |
Tinea barbae |
Bacterial folliculitis (disorder) |
Tinea barbae |
Deep bacterial folliculitis (disorder) |
Tinea barbae |
Tinea barbae (disorder) |
Tinea cruris |
Tinea cruris (disorder) |
Tinea cruris |
Tinea of perianal region (disorder) |
Tinea imbricata |
Tokelauan |
Tinea imbricata |
Tinea imbricata |
Tinea imbricata |
Tinea caused by Trichophyton concentricum (disorder) |
Tinea nigra |
Tinea nigra |
Tinea nigra |
Microsporosis nigra |
Tinea nigra |
Infection by Cladosporium werneckii |
tinea pedis orsakad av kombinerad eller samtidig infektion |
Tinea pedis |
Tinea profunda |
Deep seated dermatophytosis |
Tinea profunda |
Tinea profunda |
Tinea unguium |
Onychomycosis (disorder) |
Tinea unguium |
Onychomycosis due to dermatophyte |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
tinzaparinnatrium 10 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,25 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 10 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,35 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 10 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,45 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 10 000 IE/ml, injektionsvätska, lösning, flaska 2 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 20 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 20 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,7 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 20 000 IE/ml, injektionsvätska, lösning, förfylld spruta 0,9 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tinzaparinnatrium 20 000 IE/ml, injektionsvätska, lösning, flaska 2 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
tiokonazol 28 %, lösning |
Tioconazole 283 mg/mL cutaneous solution |
Tissierellaart |
Tissierella |
Tissue cell sample |
Cytologic material |
teknik för kompletta fryssnitt av vävnad |
Tissue frozen section technique |
givare till oximeter för mätning av syremättnad i vävnad, rekonditionerad |
Oxygen sensor (physical object) |
givare till oximeter för mätning av syremättnad i vävnad, engångs |
Oxygen sensor (physical object) |
Tissue specimen from lung |
Tissue specimen from lung (specimen) |
Tissue specimen from lung |
Specimen from lung obtained by biopsy |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Tobacco smoking consumption |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
Tobacco dependence (& [dependent smoker]) |
Tobacco dependence syndrome |
juvenil papulös dermatit |
Frictional lichenoid eruption (disorder) |
juvenil papulös dermatit |
Friction dermatitis of children |
tobramycin 40 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
tobramycin 40 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tobramycin [eye] |
Product containing tobramycin in ocular dose form (medicinal product form) |
Tobramycin [respiratory use] |
Product containing tobramycin in pulmonary dose form (medicinal product form) |
Toe X-ray |
Radiographic imaging of toe (procedure) |
Toe X-ray |
Radiographic imaging of toe (procedure) |
Toe X-ray |
Radiographic imaging of toe (procedure) |
Toe: [Perionychia] or [cellulitis and abscess NOS] |
Onychia of toe (disorder) |
Toe: [Perionychia] or [cellulitis and abscess NOS] |
Paronychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Paronychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Cellulitis of toe |
Toe: [cellulitis] or [paronychia] |
Onychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Onychia of toe (disorder) |